Arkolith/Insider Trading/VKTX/Form 4

Lian Brian

President & CEO, DirectorViking Therapeutics, Inc. (VKTX) · full profile →Form 4 · filed Jul 3, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$748K
Net Open-Market Flow
-$748K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jul 3, 2025Sell(S)27K$27.80$748K2.4M
Jul 2, 2025Grant(A)48K—$02.4M

Transaction Codes

S
Open-market sale
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000950170-25-093793) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML